Table 1.

Demographic, Cardiovascular, and Clinical Characteristics of Patients With Myocardial Infarction on Admission, According to Gender

	Total, N = 1465 (100)	Males, n = 1075 (73.3)	Females, n = 390 (26.7)	P Value
Age, y	64 (13)	61 (11)	70 (14)	<0.001
STEMI, %	45.3	44	49	0.044
Hypertension, %	58.9	57	64.1	0.007
Hyperlipidemia, %	50.1	52	45.1	0.009
Diabetes mellitus, %	23.4	23.6	23	0.4
CKD, %	0.2	0.2	0.2	0.5
CDFH, %	19.4	20.9	15.3	0.008
Smoking, %	34.1	38.5	22.3	<0.001
Previous MI, %	16.1	17	13.5	0.05
Previous heart failure, %	5.2	5.0	5.6	0.3
Thrombolysis, %	3.9	4.7	1.8	0.004
1° PCI, %	27.2	29	22.3	0.005
SAP on admission, mm Hg	137 (26)	137 (22)	138 (32)	0.3
HR, bpm	79 (19)	78 (18)	81 (20)	0.003
Killip >1, %	18.7	16.9	23	0.004
Peak CK, U/L	1481 (1465)	1575 (1912)	1205 (1115)	<0.001
Plasma glucose, mg/dL	149 (71)	148 (70)	151 (68)	0.2
Total cholesterol, mg/dL	197 (47)	195 (465)	203 (51)	0.03
HDL‐C, mg/dL	44 (13)	43 (23)	55 (37)	0.001
LDL‐C, mg/dL	117 (42)	115 (41)	118 (51)	0.2
Triglycerides, mg/dL	186 (134)	195 (141)	157 (103)	0.001
VT‐VF, %	0.7	1	0.2	0.06
Reinfarction, %	0.3	0.2	0.7	0.1
Heart failure, %	7.5	6.6	10	0.01
Mortality, %	4.1	3.3	6.2	0.006

Abbreviations: CDFH, cardiovascular disease family history; CK, creatine kinase; CKD, chronic kidney disease; HDL‐C, high‐density lipoprotein cholesterol; HR, heart rate; LDL‐C, low‐density lipoprotein cholesterol; MI, myocardial infarction; PCI, percutaneous coronary intervention; SAP, systolic arterial pressure; STEMI, ST‐segment elevation myocardial infarction; VF, ventricular fibrillation; VT, ventricular tachycardia.

P value is for the comparison between males and females. Data are presented as mean (standard deviation) except where otherwise indicated.